换一批
换一批Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretion.
第一作者：
Xiu-Hua,Wu
第一单位：
Institute of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Zhejiang University, Hangzhou, PRC.
作者：
主题词
尿囊素(Allantoin);血管生成抑制剂(Angiogenesis Inhibitors);动物(Animals);青蒿素类(Artemisinins);印迹法, 蛋白质(Blotting, Western);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);鸡胚(Chick Embryo);培养基, 条件性(Culture Media, Conditioned);减量调节(Down-Regulation);酶激活(Enzyme Activation);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);细胞外信号调节MAP激酶类(Extracellular Signal-Regulated MAP Kinases);流式细胞术(Flow Cytometry);人类(Humans);膜(Membranes);多发性骨髓瘤(Multiple Myeloma);RNA, 信使(RNA, Messenger);逆转录聚合酶链反应(Reverse Transcriptase Polymerase Chain Reaction);倍半萜类(Sesquiterpenes);信号传导(Signal Transduction);四唑鎓盐类(Tetrazolium Salts);噻唑类(Thiazoles);血管内皮生长因子A(Vascular Endothelial Growth Factor A)
DOI
10.1097/01.cad.0000224443.85834.32
PMID
16926633
发布时间
2021-09-15
- 浏览22
Anti-cancer drugs
839-48页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
